Wolverine Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $619K | Buy |
4,800
+1,500
| +45% | +$180K | ﹤0.01% | 3452 |
|
|
2025
Q2 | $353K | Buy |
+3,300
| New | +$358K | ﹤0.01% | 3297 |
|
|
2025
Q1 | – | Sell |
-3,500
| Closed | -$430K | – | 5289 |
|
|
2024
Q4 | $430K | Buy |
3,500
+400
| +13% | +$47.1K | ﹤0.01% | 3568 |
|
|
2024
Q3 | $344K | Buy |
+3,100
| New | +$340K | ﹤0.01% | 3456 |
|
|
2024
Q2 | – | Sell |
-3,000
| Closed | -$361K | – | 4851 |
|
|
2024
Q1 | $361K | Sell |
3,000
-500
| -14% | -$61.2K | ﹤0.01% | 3164 |
|
|
2023
Q4 | $431K | Buy |
3,500
+1,900
| +119% | +$237K | ﹤0.01% | 3109 |
|
|
2023
Q3 | $207K | Buy |
+1,600
| New | +$213K | ﹤0.01% | 3720 |
|
|
2023
Q1 | – | Sell |
-3,200
| Closed | -$510K | – | 4586 |
|
|
2022
Q4 | $510K | Buy |
3,200
+1,500
| +88% | +$220K | ﹤0.01% | 2318 |
|
|
2022
Q3 | $225K | Buy |
+1,700
| New | +$258K | ﹤0.01% | 3471 |
|
|
2022
Q1 | – | Sell |
-4,300
| Closed | -$552K | – | 5924 |
|
|
2021
Q4 | $552K | Sell |
4,300
-5,400
| -56% | -$710K | ﹤0.01% | 3329 |
|
|
2021
Q3 | $1.28M | Sell |
9,700
-8,700
| -47% | -$1.31M | ﹤0.01% | 2679 |
|
|
2021
Q2 | $3.29M | Buy |
+18,400
| New | +$3.19M | 0.01% | 1505 |
|
|
2021
Q1 | – | Sell |
-3,000
| Closed | -$494K | – | 6147 |
|
|
2020
Q4 | $494K | Sell |
3,000
-10,100
| -77% | -$1.5M | ﹤0.01% | 3187 |
|
|
2020
Q3 | $1.83M | Buy |
13,100
+2,700
| +26% | +$335K | ﹤0.01% | 1550 |
|
|
2020
Q2 | $1.14M | Sell |
10,400
-7,000
| -40% | -$774K | ﹤0.01% | 1884 |
|
|
2020
Q1 | $1.73M | Buy |
+17,400
| New | +$2.25M | 0.01% | 1460 |
|
|
2019
Q2 | – | Sell |
-25,700
| Closed | -$3.67M | – | 4791 |
|
|
2019
Q1 | $3.67M | Buy |
25,700
+18,500
| +257% | +$2.41M | 0.01% | 1073 |
|
|
2018
Q4 | $876K | Sell |
7,200
-15,000
| -68% | -$2.23M | ﹤0.01% | 2085 |
|
|
2018
Q3 | $3.73M | Buy |
22,200
+14,700
| +196% | +$2.53M | 0.01% | 1176 |
|
|
2018
Q2 | $1.13M | Hold |
7,500
| – | – | ﹤0.01% | 2139 |
|
|
2018
Q1 | $1.13M | Buy |
7,500
+3,600
| +92% | +$528K | ﹤0.01% | 2139 |
|
|
2017
Q4 | $525K | Sell |
3,900
-3,600
| -48% | -$499K | ﹤0.01% | 2939 |
|
|
2017
Q3 | $1.1M | Buy |
7,500
+1,400
| +23% | +$212K | ﹤0.01% | 1834 |
|
|
2017
Q2 | $950K | Sell |
6,100
-5,400
| -47% | -$826K | ﹤0.01% | 1790 |
|
|
2017
Q1 | $1.68M | Buy |
11,500
+4,700
| +69% | +$612K | 0.01% | 1313 |
|
|
2016
Q4 | $741K | Buy |
+6,800
| New | +$757K | ﹤0.01% | 2208 |
|
|
2016
Q3 | – | Sell |
-8,900
| Closed | -$1.25M | – | 4825 |
|
|
2016
Q2 | $1.25M | Buy |
+8,900
| New | +$1.31M | 0.01% | 1426 |
|
Other funds holding JAZZ
EC
Wolverine Trading's JAZZ Position: Q1 2025 in Review
Wolverine Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 8,988 shares — an estimated $1.11M sold.
Wolverine Trading first reported a position in JAZZ in Q1 2017 and held it in 13 quarters. The position peaked at $1.89M in Q2 2021. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.
- Wolverine Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Wolverine Trading sold 8,988 Jazz Pharmaceuticals shares in Q1 2025, an estimated $1.11M.
- Wolverine Trading first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 13 quarters.
- Wolverine Trading's Jazz Pharmaceuticals position peaked at $1.89M in Q2 2021.
- 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.
Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.